Data / Drug companies / Amerifoods Trading Company
Amerifoods Trading Company: 19 products in the FDA NDC directory, labeler code 61504
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amerifoods Trading Company (labeler code 61504) lists 19 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 19 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 20, 2025.
The request: Watch Amerifoods Trading Company (FDA labeler code 61504): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 61504
- Products in commercial distribution
- 19
- Packages
- 30
- Finished drugs by generic name
- 13
- Prescription products
- 0
- Over the counter products
- 19
- Flagged as original packager
- 19 of 19 products that carry the flag
- Started marketing in the last 12 months
- 5
- Earliest marketing start
- October 1, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 10 | 52.6% |
| Generic drugs (ANDA) | 9 | 47.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 19 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Ibuprofen | 3 | 190 |
| Benzalkonium chloride | 2 | 271 |
| Diphenhydramine hydrochloride | 2 | 127 |
| Aspirin | 2 | 134 |
| Acetaminophen | 2 | 214 |
| Isopropyl alcohol | 1 | 177 |
| Acetaminophen and diphenhydramine hydrochloride | 1 | 29 |
| Hydrogen peroxide | 1 | 100 |
| Loratadine | 1 | 125 |
| Guaifenesin | 1 | 123 |
| Naproxen sodium | 1 | 100 |
| Cetirizine hydrochloride | 1 | 119 |
| Fexofenadine hydrochloride | 1 | 65 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, coated | 8 | 42.1% |
| Liquid | 2 | 10.5% |
| Tablet | 2 | 10.5% |
| Tablet, extended release | 2 | 10.5% |
| Tablet, chewable | 1 | 5.3% |
| Solution | 1 | 5.3% |
| Tablet, delayed release | 1 | 5.3% |
| Capsule, liquid filled | 1 | 5.3% |
| Soap | 1 | 5.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Nonsteroidal Anti-inflammatory Drug | 6 |
| Histamine-1 Receptor Antagonist | 5 |
| Platelet Aggregation Inhibitor | 2 |
| Expectorant | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Mucus Relief | 61504-204 | Tablet, extended release | Generic drugs (ANDA) | November 20, 2025 |
| Arthritis Pain | 61504-200 | Tablet, extended release | Generic drugs (ANDA) | November 20, 2025 |
| Ibuprofen | 61504-185 | Capsule, liquid filled | Generic drugs (ANDA) | November 20, 2025 |
| Low Dose Aspiriun | 61504-105 | Tablet, chewable | Over the counter monograph drugs | November 20, 2025 |
| Nighttime SleepAid | 61504-091 | Tablet, coated | Over the counter monograph drugs | November 20, 2025 |
| First Street Dishwashing Concentrate and Antibacterial Hand | 61504-552 | Soap | Over the counter monograph drugs | March 12, 2024 |
| First Street Antibacterial Liquid Hand | 61504-551 | Liquid | Over the counter monograph drugs | January 30, 2024 |
| Allergy Relief | 61504-194 | Tablet, coated | Generic drugs (ANDA) | October 30, 2023 |
| Allergy Relief | 61504-193 | Tablet | Generic drugs (ANDA) | October 30, 2023 |
| Allergy Relief | 61504-192 | Tablet | Generic drugs (ANDA) | October 30, 2023 |
| Naproxen Sodium | 61504-145 | Tablet, coated | Generic drugs (ANDA) | October 30, 2023 |
| Ibuprofen | 61504-110 | Tablet, coated | Generic drugs (ANDA) | October 30, 2023 |
| Ibuprofen | 61504-109 | Tablet, coated | Generic drugs (ANDA) | October 30, 2023 |
| Acetaminophen | 61504-104 | Tablet, coated | Over the counter monograph drugs | October 30, 2023 |
| Pain Relief PM | 61504-095 | Tablet, coated | Over the counter monograph drugs | October 30, 2023 |
| Allergy Relief | 61504-090 | Tablet, coated | Over the counter monograph drugs | October 30, 2023 |
| Aspirin | 61504-080 | Tablet, delayed release | Over the counter monograph drugs | October 30, 2023 |
| Hydrogen Peroxide | 61504-871 | Solution | Over the counter monograph drugs | February 9, 2017 |
| Iris | 61504-810 | Liquid | Over the counter monograph drugs | October 1, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.